Skip to product information
1 of 1

Ascend Aus

[2V] Retatrutide + Cagrilintide Research Duo (separate vials)

[2V] Retatrutide + Cagrilintide Research Duo (separate vials)

Regular price $229.95 AUD
Regular price $229.95 AUD Sale price $160.97 AUD 30% off
Sold out
Taxes included. Shipping calculated at checkout.
Format
Quantity

FREE Express Shipping on orders $149+ – select Express at checkout. Australian addresses; order total after discounts.

Pay by bank transfer after you place your order. Dispatch starts after payment has cleared. How to pay
View full details

Product documentation

Review the documentation relevant to the product and batch before purchase.

Dispatch from NSW

Tracked Australian express delivery — free at $149 discounted merchandise for eligible Australian addresses; checkout confirms eligibility.

Secure Checkout

Secure payment options shown at checkout

Order support

If something goes wrong with your order, contact us. Our Refund Policy explains available remedies.

Retatrutide + Cagrilintide Research Duo (separate vials)

A two-vial research set supplying Retatrutide 10mg and Cagrilintide 10mg as separate vials rather than a premixed blend. Dispatched from within Australia for laboratory research use only.

Set Contents

Retatrutide 10mg 39-amino-acid triple receptor agonist, CAS 2381089-83-2
Cagrilintide 10mg Long-acting amylin analogue (AM833), CAS 1415456-99-3

Pricing

Purchased individually at current prices these vials total $269.90. The set is offered at $229.95 — Save $39.95 vs buying separately.

Specifications

Format Lyophilised powder, two separate vials

Research Context

These two compounds act on different receptor families — Retatrutide on the incretin receptors (GIPR, GLP-1R, GCGR) and Cagrilintide on the amylin receptor. Research literature frequently examines incretin and amylin analogues alongside one another, which is why they are catalogued as a pair. This set supplies them as two independent vials, so each can be handled and stored separately. Ascend Aus supplies these compounds strictly as laboratory reference materials; no representation is made regarding any physiological outcome, and they are not supplied for use in humans or animals.

Frequently Asked Questions

Are both compounds GLP-1 analogues?
No. Retatrutide acts on incretin receptors; Cagrilintide is an amylin analogue acting on a separate receptor family.

Is this one vial or two?
Two separate vials — nothing is premixed.

What strengths are supplied?
10mg of each compound. Other Retatrutide strengths are available on the individual Retatrutide listing.

How is the set stored?
Refer to the documentation applicable to the supplied product. Contact Ascend Aus if you need clarification.

Where does Ascend Aus ship from?
Orders are dispatched from within Australia.

Important Notice

Supplied for laboratory research use only. Not for human or veterinary use, self-administration, clinical, diagnostic, or therapeutic application. These products are not cosmetic, drug, or food products. The purchaser is responsible for compliance with all applicable regulations. By purchasing, you confirm that you are a qualified researcher or are acting on behalf of a research institution.

Lyophilised powder Store 2–8°C
!
Important Notice

Supplied for laboratory research purposes only. Not approved for human or veterinary use, self-administration, or therapeutic application. Handle in accordance with applicable research regulations.